PreventionGenetics Laboratory Stewardship - Insurance Advocacy at its Best
At PreventionGenetics we try to go above and beyond to help patients get the insurance coverage they deserve. We recently discovered an important issue with our Medicare Local Coverage Determination (LCD) L35000 that governs genetic testing for WI, MN and IL. Claims for BRCA1/2 testing (CPT Code 81162) submitted to the contractor that covers this 3 state region would be denied unless the patient was assigned one of two specific breast cancer ICD-10 codes.
We’ve done a complete overhaul of our hereditary cancer test menu
We are pleased to introduce highlights to our new cancer testing menu:
Improvements in laboratory technologies allow us to pass along savings to the patient. Most of our cancer tests are now available for $540.
New buccal specimen collection kits available
President's Corner - Exome Tests are Not All the Same
Many think that exome sequencing tests from different labs are basically the same and that the only important differentiator is price. In reality, exome (and genome) sequencing tests vary greatly among labs.
PGxome®-Based Tests Validated for Copy Number Variants
We are pleased to announce that all of PreventionGenetics’ PGxome® (whole exome sequencing) based sequencing tests are now validated for copy number variant (CNV) detection. In many cases, this will alleviate the need for chromosomal microarray (CMA) or gene-centric array Comparative Genomic Hybridization(aCGH) tests, thereby increasing the value for you and your patients!